Syndex Bio
Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
Funding
Every round, secondary, debt facility or acquisition involving Syndex Bio that Lounge tracks, newest first. Latest: Seed on Feb 23, 2026.
Timeline · 1
Round
Seed · $15.5M at $61M
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in